Aridis provides corporate update

Los gatos, calif., march 31, 2023 (globe newswire) -- aridis pharmaceuticals, inc. (nasdaq: ards) (“aridis” or the “company”), a biopharmaceutical company, today announced a corporate update on recent developments.
ARDS Ratings Summary
ARDS Quant Ranking